We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$60.8B
1-Year Est. Return
42.06%
This Fund
S&P 500
This Quarter
Est. Return
-2.2%
1 Year Est. Return
+42.06%
3 Year Est. Return
+131.09%
5 Year Est. Return
+176.11%
10 Year Est. Return
–
AUM
$53.7B
AUM Growth
-$2.95B
(-5.2%)
Cap. Flow
+$168M
Cap. Flow
% of AUM
0.31%
Top 10 Holdings %
Top 10 Hldgs %
35.03%
Holding
1,742
New
57
Increased
475
Reduced
480
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$234M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$120M |
| 3 |
Micron Technology
MU
|
+$114M |
| 4 |
CoStar Group
CSGP
|
+$112M |
| 5 |
Linde
LIN
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FTAI Aviation
FTAI
|
+$421M |
| 2 |
AbbVie
ABBV
|
+$174M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$126M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$107M |
| 5 |
Capital One
COF
|
+$84.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.44% |
| 2 | Financials | 12.06% |
| 3 | Healthcare | 11.81% |
| 4 | Communication Services | 9.87% |
| 5 | Consumer Discretionary | 9.04% |
Similar funds
RIM
Ensign Peak Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Ensign Peak Advisors held 1,742 positions worth $53.7B, down 5.2% from $56.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Ensign Peak Advisors's Q1 2026 filing shows 57 new, 475 increased, 480 reduced and 34 closed positions. Its largest new stake was Novo Nordisk: 400,384 shares worth $14.7M. The largest sale was FTAI Aviation, an estimated $421M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Healthcare.
- Ensign Peak Advisors's largest Q1 2026 buy was Novo Nordisk: 400,384 shares worth $14.7M.
- Ensign Peak Advisors added most to Boston Scientific in Q1 2026, an estimated $234M increase.
- Ensign Peak Advisors's biggest Q1 2026 reduction was FTAI Aviation, cutting an estimated $421M.
- Ensign Peak Advisors fully exited Exact Sciences in Q1 2026, selling an estimated $17M.
- Ensign Peak Advisors's ten largest holdings make up 35% of its $53.7B portfolio in Q1 2026.
- Ensign Peak Advisors opened 57 new positions and closed 34 in Q1 2026.
- Ensign Peak Advisors's portfolio value fell 5.2% quarter-over-quarter to $53.7B.
Based on Ensign Peak Advisors's 13F filing for Q1 2026, filed 13 May 2026.